NEOG(Neogen Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-05-31 | FY 截至 2023-05-31 | FY 截至 2024-05-31 | FY 截至 2025-05-31 | FY 截至 2026-05-31 |
|---|---|---|---|---|---|
| 营业收入 | $527.16M | $822.45M | $924.20M | $894.70M | $870.40M |
| 毛利润 | $243.01M | $405.95M | $463.90M | $421.40M | $408.50M |
| 营业利润 | $58.62M | $37.52M | $58.60M | −$1.06B | −$21.60M |
| 净利润 | $48.31M | −$22.87M | −$9.40M | −$1.09B | −$7.90M |
| 经营现金流 | $68.04M | $41.03M | $35.30M | $58.20M | $83.20M |
| 自由现金流 | $43.61M | −$24.73M | −$76.10M | −$46.40M | $31.90M |
| 摊薄每股收益 | $0.45 | $-0.12 | $-0.04 | $-5.03 | $-0.04 |